| Sarah Piekarski, | |
|
310 S Main St Ste D, Lombard, IL 60148-2692 | |
| (630) 652-0200 | |
| (630) 652-0300 |
| Full Name | Sarah Piekarski |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 310 S Main St Ste D, Lombard, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164881272 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146012697 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Piekarski, 310 S Main St Ste D, Lombard, IL 60148-2692 Ph: (630) 652-0200 | Sarah Piekarski, 310 S Main St Ste D, Lombard, IL 60148-2692 Ph: (630) 652-0200 |
News Archive
Despite the national consensus on the need to improve the value of health care while reducing unnecessary spending, teaching hospitals often struggle to design curricula to train future physicians to deliver such care to their patients.
QRxPharma Limited announced today initiation of the New Drug Application (NDA) approval process for MoxDuo IR with the United States Food and Drug Administration (FDA). This NDA submission sets the stage for the regulatory approval process for MoxDuo IR for the treatment of moderate to severe acute pain, a $2.5 billion segment of the $8 billion spent annually on prescription opioids in the US.
A novel software tool, developed at The Children's Hospital of Philadelphia, streamlines the detection of disease-causing genetic changes through more sensitive detection methods and by automatically correcting for variations that reduce the accuracy of results in conventional software.
Simoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A haemophilia, an inherited disorder that impairs blood clotting. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier, however, because the drug manufacturer did not submit any suitable data.
Studies show "the profound impact of antiretroviral-therapy coverage at a population level" - how wider coverage can increase life expectancy and reduce the risk of HIV infection.
› Verified 6 days ago
Mrs. Christina Szczepanek, MSCCCSLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2100 S Finley Rd, Lombard, IL 60148 Phone: 630-495-4000 Fax: 630-953-8005 | |
Naima Zaheer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1125 S Main St Ste D, Lombard, IL 60148 Phone: 630-916-3000 | |
Tara Holden, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 S Main St Ste D, Lombard, IL 60148 Phone: 630-652-0200 Fax: 630-652-0300 | |
Meredith Ellen Blair, MS SLP CFY Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 S Main St, D, Lombard, IL 60148 Phone: 630-652-0200 Fax: 630-652-0300 | |
Brittany Armstrong, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 S Main St Ste D, Lombard, IL 60148 Phone: 630-652-0200 | |
Elyse Engelhart, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 43 N Glenview Ave, Lombard, IL 60148 Phone: 630-666-4530 | |
Jordan Felkey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 S Main St Ste D, Lombard, IL 60148 Phone: 630-652-0200 |